Roche, the Swiss pharmaceutical giant, found itself inadvertently in the spotlig...
Medtronic’s pursuit of FDA approval for its blood pressure treatment device has ...
Novo Nordisk is eyeing the cardiology treatment space for its highly sought-afte...
The US Food and Drug Administration's recent accelerated approval of Pfizer's El...
Novo Nordisk has engaged Thermo Fisher as a contract manufacturer to produce the...
The US Food and Drug Administration (FDA) has granted clearance to Gilead Scienc...
In light of the conviction of UK nurse Lucy Letby for murder, doctors are callin...
Patient data sharing among various stakeholders for research purposes forms the ...
Merck (MSD) and AstraZeneca have received approval in Japan for Lynparza to trea...
The Sandoz biosimilar, Tyruko, was approved by the US FDA for all labelled indic...
The latest fundraise will close in 2024, with plans for one Phase II trial to st...
Soliris is already approved to treat refractory generalised myasthenia gravis in...
GOP candidates debated over just how far the party should go on national abortio...
Good morning, Pharmalittle readers. Reporter Andrew Joseph here filling in for E...
Drugmakers already bet big on mRNA for cancer. So why is Biden's new health agen...
Medical professionals often find it very difficult to seek medical care for them...
